Cargando…

Longitudinal tau PET in ageing and Alzheimer’s disease

See Hansson and Mormino (doi:10.1093/brain/awy065) for a scientific commentary on this article. Our objective was to compare different whole-brain and region-specific measurements of within-person change on serial tau PET and evaluate its utility for clinical trials. We studied 126 individuals: 59 c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jack, Clifford R, Wiste, Heather J, Schwarz, Christopher G, Lowe, Val J, Senjem, Matthew L, Vemuri, Prashanthi, Weigand, Stephen D, Therneau, Terry M, Knopman, Dave S, Gunter, Jeffrey L, Jones, David T, Graff-Radford, Jonathan, Kantarci, Kejal, Roberts, Rosebud O, Mielke, Michelle M, Machulda, Mary M, Petersen, Ronald C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917767/ https://www.ncbi.nlm.nih.gov/pubmed/29538647 http://dx.doi.org/10.1093/brain/awy059

Ejemplares similares

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
por: Jack, Clifford R, et al.
Publicado: (2019)

Predicting future rates of tau accumulation on PET
por: Jack, Clifford R, et al.
Publicado: (2020)

Predicting amyloid PET and tau PET stages with plasma biomarkers
por: Jack, Clifford R, et al.
Publicado: (2023)

Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study
por: Jack, Clifford R., et al.
Publicado: (2017)

Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework
por: Jack, Clifford R., et al.
Publicado: (2019)

Rates of transition between amyloid and neurodegeneration biomarker states and to dementia among non-demented individuals: a population-based cohort study
por: Jack, Clifford R., et al.
Publicado: (2015)

Relationships between β-amyloid and tau in an elderly population: An accelerated failure time model
por: Therneau, Terry M., et al.
Publicado: (2021)

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
por: Jack, Clifford R., et al.
Publicado: (2015)

Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk
por: Jack, Clifford R., et al.
Publicado: (2022)

Associations of quantitative susceptibility mapping with Alzheimer’s disease clinical and imaging markers
por: Cogswell, Petrice M., et al.
Publicado: (2020)

NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages
por: Petersen, Ronald C., et al.
Publicado: (2021)

Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging
por: Vemuri, Prashanthi, et al.
Publicado: (2018)

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
por: Vemuri, Prashanthi, et al.
Publicado: (2015)

Association of Apolipoprotein E ɛ4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults
por: Ramanan, Vijay K, et al.
Publicado: (2019)

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
por: Schwarz, Christopher G., et al.
Publicado: (2023)

Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes
por: Marks, Jordan D., et al.
Publicado: (2021)

White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease
por: Tian, Jianqiao, et al.
Publicado: (2023)

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration
por: Jack, Clifford R., et al.
Publicado: (2014)

Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation
por: Schwarz, Christopher G., et al.
Publicado: (2021)

Face recognition from research brain PET: An unexpected PET problem
por: Schwarz, Christopher G., et al.
Publicado: (2022)

Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET
por: Nedelska, Zuzana, et al.
Publicado: (2018)

Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
por: Zeydan, Burcu, et al.
Publicado: (2020)

Evidence against a temporal association between cerebrovascular disease and Alzheimer’s disease imaging biomarkers
por: Cogswell, Petrice M., et al.
Publicado: (2023)

Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values
por: Schwarz, Christopher G., et al.
Publicado: (2018)

A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
por: Schwarz, Christopher G., et al.
Publicado: (2019)

Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging
por: Neth, Bryan J., et al.
Publicado: (2020)

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
por: Raghavan, Sheelakumari, et al.
Publicado: (2022)

Cross–scanner harmonization methods for structural MRI may need further work: A comparison study
por: Gebre, Robel K., et al.
Publicado: (2023)

Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging
por: Vemuri, Prashanthi, et al.
Publicado: (2019)

Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults
por: Arenaza-Urquijo, Eider M., et al.
Publicado: (2020)

Longitudinal deterioration of white-matter integrity: heterogeneity in the ageing population
por: Poulakis, Konstantinos, et al.
Publicado: (2021)

Advancing Tau-PET quantification in Alzheimer’s disease with machine learning: introducing THETA, a novel tau summary measure
por: Gebre, Robel K., et al.
Publicado: (2023)

Non-Stationarity in the “Resting Brain’s” Modular Architecture
por: Jones, David T., et al.
Publicado: (2012)

White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline
por: Vemuri, Prashanthi, et al.
Publicado: (2021)

Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual
por: Schwarz, Christopher G., et al.
Publicado: (2022)

MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous
por: Josephs, Keith A., et al.
Publicado: (2020)

(1)H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults
por: Nedelska, Zuzana, et al.
Publicado: (2017)

Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease
por: Sintini, Irene, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vaquetebqm8r8le4dobh9mfeut